Results 111 to 120 of about 4,794 (200)

A case of endemic Kaposi sarcoma mimicking morphea. [PDF]

JAAD Case Rep
George DS, Haile BG, Mengesha EY, Hayato AS, Idris H, Kamboj S, Braun H, Gebremariam AM, Kidane TY.   +8 more
europepmc   +1 more source

Intertriginous bullous morphea: A clue for the pathogenesis?

, 2007
Bullae occurring in lesions of morphea are uncommon. The cause of bullae formation in morphea is multifactorial, although lymphatic obstruction from the sclerodermatous process is considered the likeliest cause. Bullous morphea may be confused clinically
Zindand, Ilkin, Beyhan, Emek Kocatuerk Seyhan, Kavala, Mukaddes, Demirkesen, Cuyan, Turkoglu, Zafer   +4 more
core  

Facial restoration of morphea and Parry-Romberg syndrome with resilient hyaluronic acid: a case report. [PDF]

Int J Womens Dermatol
Patin E, Santiago Mangual KP, Kourosh AS, Lim YH, Tsao S.   +4 more
europepmc   +1 more source

Assessing the response of morphea and limited scleroderma to tranilast: a small prospective study comparing topical corticosteroids to a combination of topical corticosteroids and tranilast

, 2018
Rowland Noakes Queensland Institute of Dermatology, Greenslopes Private Hospital Campus, Greenslopes, QLD, Australia Background: Scleroderma is traditionally managed with immunomodulatory agents such as methotrexate, mycophenolate mofetil and ...
Noakes R
core  

Upadacitinib for recalcitrant extragenital morphea and lichen sclerosus overlap: A case report. [PDF]

JAAD Case Rep
Rasul T, Hemmerich CE, Cooper B, Tehrani L, Krishnamurthy K.   +4 more
europepmc   +1 more source

Erratum to Wu J, Bae J, Chen C, Ryu S, Lozeau D, Stessin A, Prasanna P. Magnetic resonance imaging radiomic analysis of radiation-induced morphea of the breast: a proof-of-concept study. Adv Radiat Oncol 2025;10:101881. [PDF]

Adv Radiat Oncol
Wu J, Bae J, Chen C, Ryu S, Lozeau D, Stessin A, Prasanna P.   +6 more
europepmc   +1 more source

IL-17 Signaling Inhibitors in Localized Scleroderma: A Single-Center Case Series of Nine Patients. [PDF]

J Dermatol
Takahashi T, Takahashi T, Segawa Y, Oka K, Takahashi T, Asano Y.   +5 more
europepmc   +1 more source

UVA-1 therapy for sclerosing skin disease: A pilot study of patient and clinician-reported outcomes in a single-arm nonrandomized trial. [PDF]

JAAD Int
Noot CH, Hopkins Z, Seely MM, Seifert RM, Gray L, Sahni V, Jimenez A, Secrest A, Hansen CB.   +8 more
europepmc   +1 more source

In morphea, cytotoxic resident memory T cells induce chronic, immunogenic endothelial cell injury via necroptosis. [PDF]

JCI Insight
Crisler WJ, Sohail N, Steuart SJ, Vazquez-Machado M, Mahajan A, Whittelsey M, Pickering A, Martinez MJ, Hutchins T, Teague JE, Zhan Q, Ho Sui S, Vleugels RA, Torok KS, Jacobe H, Clark RA, LaChance A.   +16 more
europepmc   +1 more source

Cervical Spine Involvement in Morphea Patients With Subclinical Neurologic Signs. [PDF]

Cureus
Critelli M, Davis T, Flume H, Sarameh Y, Baer CB, Shabbir R, Schwartz JT.   +6 more
europepmc   +1 more source